Forum for Collaborative HIV Research
The Forum addresses cutting edge science and policy issues through a process of stakeholder engagement and deliberation The Forum includes representatives from government, industry, patient advocates, health care providers, academia and foundations.
An Executive Committee, including members from each of these groups, and the Forum directors set the research agenda for the Forum. The Executive Committee meets regularly to identify, discuss and prioritize emerging issues. Ideas for projects are usually brought to the table by Executive Committee members but may also be submitted by other members of the HIV community.
Forum for Collaborative HIV Research
WHO Highlights Hepatitis Testing Innovations at the International Liver Congress
Innovative hepatitis testing projects from five countries were commended by the World Health Organization (WHO) at an award ceremony and symposium about hepatitis testing last Sunday morning, 17 April 2016, at The International Liver Congress™ (ILC) in Barcelona, Spain.
The National Academies of Science, Engineering and Medicine Releases New Report on Hepatitis
It is possible to end the transmission of hepatitis B and C and prevent further sickness and deaths from the diseases, but time, considerable resources, and attention to various barriers will be required, says a new report from the National Academies of Sciences, Engineering, and Medicine.
EATG Conference: Ageing with HIV
The European AIDS Treatment Group (EATG – www.eatg.org) runs a comprehensive project to explore, from the patients' perspective, different aspects of ageing with HIV from childhood to mature ages. Following a series of webinars, the EATG organized the first conference about the special biomedical and social particularities and needs of people living with HIV older than 50 years of age in Berlin between 31 March and 3 April 2016.
GLOBAL HIV VACCINE ENTERPRISE: INNOVATIVE USES OF TECHNOLOGY IN HIV CLINICAL TRIALS
Meeting Description: The HIV vaccine field has a large and diverse pipeline of candidates advancing to the various stages of clinical testing.
AIDS 2016 - 21ST INTERNATIONAL AIDS CONFERENCE: PLENARY SPEAKERS ANNOUNCED
Breakthrough agreement to accelerate HIV cure research achieved
Common Material Transfer Agreement will accelerate the search for a cure. The International AIDS Society (IAS) today announced the finalisation of a Common Material Transfer Agreement (cMTA) for the donation and use of antiretroviral drugs for preclinical studies in HIV cure research.
On Behalf of the HIV Medicine Association (HIVMA)
ARV Guideline Panel Seeks Nominations
The Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents is accepting nominations for new scientific and clinical members with HIV medicine expertise, as well as nominations for new community members, who will serve four-year terms beginning in April 2016.
The Panel is seeking scientific and clinical members who are recognized experts in HIV research and care in any of the following areas: adolescent medicine, biostatistics, HIV drug resistance, and hepatitis coinfection.
The Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents is accepting nominations for new scientific and
On Behalf of the Social Entrepreneurship for Sexual Health (SESH) Team
& the WHO Global Hepatitis Program
Call for Contributions: Hepatitis Testing Innovation Contest #HEPCONTEST
Our SESH (Social Entrepreneurship for Sexual Health) team in collaboration with the WHO Global Hepatitis Program is organizing an innovation contest on hepatitis B and C testing. The purpose of this contest is to identify innovative examples of delivering hepatitis B and C testing that will be highlighted within the 2016 WHO Hepatitis Testing Guidelines. The innovation could be delivery to a new population, in a new setting (e.g. prisons), or a new messaging approach to encourage testing uptake (e.g. social media). The goal is to identify interventions aimed to increase testing, providing real-world examples to be used alongside the WHO Hepatitis Testing Guidelines.
Your submission, in the form of a 300-500 word description of your innovation and its impact, must be submitted by March 1, 2016. Submissions in English are encouraged; however, we will accept entries in Arabic, Chinese, French, Russian, and Spanish. Send us your creative contribution!
Call for contributions Our SESH (Social Entrepreneurship for Sexual Health) team in collaboration with the WHO Global Hepatitis Program is organizing an
On Behalf of the HIV Prevention Trials Network (HPTN)
Application Deadline for 2016-2017 HPTN Scholars Program Extended
The HIV Prevention Trials Network (HPTN), a global network of HIV researchers funded by the National Institutes of Health, is proud to offer two types of scholarships for early-career investigators, one for U.S. investigators and one for international investigators. The HPTN Scholars Programs are funded by supplements from the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH), and the National Institute on Drug Abuse (NIDA).
These scholarships provide funding to cover a portion of a scholar’s time (typically ~10-30%), travel to two scientific meetings and one skills-building/networking workshop, and other expenses. All applicants should be investigators who are eager for the opportunity to work with a mentor scientist to complete a research project based upon an existing domestic HIV research study in the HPTN.
The International AIDS Society (IAS) is seeking proposals for a consultant to act as Coordinator of the Adolescent HIV Treatment Coalition (ATC).
On Behalf of Michael Lederman MD, Editor-in-Chief
Launch of Pathogens and Immunity Journal
Michael M. Lederman MD, Editor-in-Chief, is excited to announce the launch of Pathogens and Immunity (P&I), a new electronic, open access journal that will focus on original research in microbiology, immunology and infectious disease. Pathogens and Immunity has a particular interest in publishing translational manuscripts, that is, work that has important implications for human health and disease.
Calling all DC-Area Interns! On August 4th, 2015, the Forum for Collaborative HIV Research will host the 2015 Washington Area Interns Networking Day. Leading experts in HIV/AIDS and Viral Hepatitis will gather for a panel discussion in which they will provide career advice and shared their personal experiences navigating the fields of Public Health and Public Policy. Visit http://www.hivforum.org/forum-news/upcoming-events/1166-2015-washington-area-interns-networking-day- for more information and to register!
On August 4th, 2015, the Forum for Collaborative HIV Research will host the 2015 Washington Area Interns Networking Day.
The early registration deadline for the 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care is May 13, 2015. Registration fees increase after May 13th.
(includes 2 nights hotel, all meals during conference and access to all sessions)
Individuals from academic institutions or not-for-profit organizations - $900.00
Individuals from Industry - $1,600.00
(includes all meals during conference and access to all sessions)
Individuals from academic institutions or not-for-profit organizations - $500.00
Individuals from Industry - $1,000.00
The Forum has a job opening for an Assistant in its Washington, DC office. For more information about the position, and to apply, please click the link below:
Thanks again to our panelists, Jeffrey Crowley, Corinna Dan, Christine Lubinski, Ivy Turnbull, and Andrea Weddle for speaking at Interns Networking Day 2014! http://tiny.cc/kd3fkx
On Monday, August 4, 2014, the Forum for Collaborative Research hosted its annual Washington Area Interns Networking Day.
Only a few spots left 4 our Washington #DC #Interns Networking Day! Q&A w/ #publichealth & policy leaders. Register @ hivforum.org/2014ind
On August 4, 2014, the Forum for Collaborative HIV Research will host the Washington Area Interns Networking Day 2014 .�
Interns attend Congressional Briefing on #FY2015’s elimination of #RyanWhite Part D & its effect on #WomenandHIV: tinyurl.com/pss77jo
We at the Forum for Collaborative HIV Research deeply mourn the deaths of all of the 298 persons on Malaysian Airlines flight MH17, among them many individuals traveling to the International AIDS Conference in Melbourne. There are no words to adequately describe the loss to the field caused by this shocking and horrifying event. An International AIDS Conference without Joep Lange is unimaginable – made even sadder because this new reality is forever. Together with the global AIDS community, we grieve the loss of this exceptional leader, colleague, mentor and collaborator. We remember the ceaselessness and tirelessness of his commitment to ensure treatment of all people no matter who or where, his persistence in pushing the envelope of regional and global policy, and his insistence on the utmost rigorous science and impatience and intolerance of anything but. Most of all, we remember his human side – honest, direct, often blunt but always caring friend to many of us. Our sincerest condolences to family and friends of Joep Lange, Jacqueline van Tongeren and the other victims of the crash.
For Release: Experts Propose New Terminology for HCV Drug Trials New Definitions Intended to Accelerate Innovation in Drug Development
#FF @HarmReduction @HealthBizBlog @SciSpeaksBlog
2012 National Summit Update: Abstracts, Posters, Presentations and Photos Now Available
Journal Club: USPSTF Birth Cohort Screening Recommendations with Dr. John Ward and Others
Sec. Sebelius Delivers Keynote Address at 2012; C. Everett Koop Award and Video Tribute to Henry Waxman
For Release: Nat'l Summit on HIV & Viral Hepatitis Convenes Nov. 26-28 in DC; Focus on Accelerating HIV and Viral Hepatitis Testing, Reducing Care Disparities
Evening session registration for the 2012 National Summit.
Register to attend one evening session of the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care. The evening session registration rate is $125. This option is available for each of the following sessions:
Secretary Sebelius to Deliver Keynote Address at 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care
Secretary Kathleen Sebelius will deliver the Keynote Address during the Opening Plenary session of the2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care. This session will begin at5:00 pmonMonday, November 26, 2012.Space is limited and registrations will be acc...
Reminder: Early Registration Ends This Sunday, November 4th for 2012 National Summit. Register today!
2012 Summit Updates: Special Performance from the Medea Project; Plenary Speakers; Register Today
Plenary Speakers and Updated Program for 2012 National Summit on HIV and Viral Hepatitis. Register Today!
Representative Henry Waxman Announced as the Recipient of the 2012 C. Everett Koop HIV/AIDS Public Health Leadership Award
Register Today - 2012 National Summit on HIV and Viral Hepatitis. The program will consist of plenary sessions at the beginning and end of the conference. Breakout sessions on Routine and Expanded Testing, Prevention Models, Outcomes and Impact Evaluation, and Access, Linkage and Retention in Care will allow in-depth discussion of these topics.
Register Today - 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care
HCV Drug ResisSS 2012 v1.2; Forum-Medscape HIV Prevention Roundtable; 17th IWHOD; Janssen Seeks Applications
The2013 International Workshop on HIV Observational Databases(IWHOD) will take place inCavtat, CroatiaonApril 11-13, 2013. IWHOD has become one of the most sought-after meetings for those involved in outcomes research based on cohorts and observational databases. The Scientific Committee and Organ...
Registration is Now Open - 2012 National Summit on HIV and Viral Hepatitis
Registration Begins Friday 9/28 - 2012 National Summit on HIV and Viral Hepatitis
1608 Rhode Island Ave NW
Washington D.C., DC
Founded in 1997, The Forum for Collaborative HIV Research is a public/private partnership at the University of California, Berkeley Washington Campus. The Forum's mission is to enhance and facilitate HIV research and this is accomplished by bringing together all relevant stakeholders to address emerging issues in HIV/AIDS. Through our work, we identify gaps and impediments, frame issues and help set research strategy. The goal is to optimize care and treatment of those affected by HIV/AIDS and our scope includes research addressing prevention, treatment strategy, health services utilization and health policy.
Be the first to know and let us send you an email when Forum for Collaborative HIV Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Forum for Collaborative HIV Research: